A comparative trial of brincidofovir in patients with serious adenovirus infection: Study 999

Trial Profile

A comparative trial of brincidofovir in patients with serious adenovirus infection: Study 999

Planning
Phase of Trial: Phase III

Latest Information Update: 09 May 2017

At a glance

  • Drugs Brincidofovir (Primary)
  • Indications Adenovirus infections
  • Focus Registrational; Therapeutic Use
  • Acronyms AdAPT; Study 999
  • Most Recent Events

    • 09 May 2017 If positive, data from this trial could enable regulatory approval in Europe for oral BCV, according to a Chimerix media release.
    • 07 Nov 2016 According to a Chimerix media release, the company expects to initiate in 2017.
    • 29 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top